Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("PAPAKOSTAS, George I")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 88

  • Page / 4
Export

Selection :

  • and

Evidence for S-Adenosyl-L-Methionine (SAM-e) for the Treatment of Major Depressive DisorderPAPAKOSTAS, George I.The Journal of clinical psychiatry. Supplement. 2009, Vol 70, Num 5, pp 18-22, 5 p.Article

Managing Partial Response or Nonresponse: Switching, Augmentation, and Combination Strategies for Major Depressive DisorderPAPAKOSTAS, George I.The Journal of clinical psychiatry. Supplement. 2009, Vol 70, Num 6, pp 16-25, 10 p.Article

Limitations of contemporary antidepressants : TolerabilityPAPAKOSTAS, George I.The Journal of clinical psychiatry. Supplement. 2007, Vol 68, Num 10, pp 11-17, 7 p.Article

Does the Presence of an Open-Label Antidepressant Treatment Period Influence Study Outcome in Clinical Trials Examining Augmentation/Combination Strategies in Treatment Partial Responders/Nonresponders With Major Depressive Disorder?LOVIENO, Nadia; PAPAKOSTAS, George I.The Journal of clinical psychiatry. 2012, Vol 73, Num 5, pp 676-683, issn 0160-6689, 8 p.Article

A meta-analysis of clinical trials comparing the serotonin (5HT)-2 receptor antagonists trazodone and nefazodone with selective serotonin reuptake inhibitors for the treatment of major depressive disorderPAPAKOSTAS, George I; FAVA, Maurizio.European psychiatry. 2007, Vol 22, Num 7, pp 444-447, issn 0924-9338, 4 p.Article

Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorderPAPAKOSTAS, George I; FAVA, Maurizio.Dialogues in clinical neuroscience. 2008, Vol 10, Num 4, pp 439-451, issn 1294-8322, 13 p.Article

A metaanalysis of clinical trials comparing moclobemide with selective serotonin reuptake inhibitors for the treatment of major depressive disorderPAPAKOSTAS, George I; FAVA, Maurizio.Canadian journal of psychiatry. 2006, Vol 51, Num 12, pp 783-790, issn 0706-7437, 8 p.Article

Correlation Between Different Levels of Placebo Response Rate and Clinical Trial Outcome in Major Depressive Disorder: A Meta-AnalysisLOVIENO, Nadia; PAPAKOSTAS, George I.The Journal of clinical psychiatry. 2012, Vol 73, Num 10, pp 1300-1306, issn 0160-6689, 7 p.Article

Treatment-resistant depressionSOUERY, Daniel; PAPAKOSTAS, George I; TRIVEDI, Madhukar H et al.The Journal of clinical psychiatry. 2006, Vol 67, pp 16-22, issn 0160-6689, 7 p., SUP6Article

Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorderSHELTON, Richard C; PAPAKOSTAS, George I.Acta psychiatrica Scandinavica. 2008, Vol 117, Num 4, pp 253-259, issn 0001-690X, 7 p.Article

Efficacy of Antidepressants for Dysthymia: A Meta-Analysis of Placebo-Controlled Randomized TrialsLEVKOVITZ, Yeciel; TEDESCHINI, Enrico; PAPAKOSTAS, George I et al.The Journal of clinical psychiatry. 2011, Vol 72, Num 4, pp 509-514, issn 0160-6689, 6 p.Article

Atypical Antipsychotic Augmentation in Major Depressive Disorder: A Meta-Analysis of Placebo-Controlled Randomized TrialsNELSON, J. Craig; PAPAKOSTAS, George I.The American journal of psychiatry. 2009, Vol 166, Num 9, pp 980-991, issn 0002-953X, 12 p.Article

Treatment of SSRI-Resistant Depression : A Meta-Analysis Comparing Within-Versus Across-Class SwitchesPAPAKOSTAS, George I; FAVA, Maurizio; THASE, Michael E et al.Biological psychiatry (1969). 2008, Vol 63, Num 7, pp 699-704, issn 0006-3223, 6 p.Article

Effects of psychiatric disorders and psychotropic medications on prolactin and bone metabolismMISRA, Madhusmita; PAPAKOSTAS, George I; KLIBANSKI, Anne et al.The Journal of clinical psychiatry. 2004, Vol 65, Num 12, pp 1607-1618, issn 0160-6689, 12 p.Article

Folates and S-Adenosylmethionine for Major Depressive Disorder : Complementary and Alternative MedecinePAPAKOSTAS, George I; CASSIELLO, Clair F; LOVIENO, Nadia et al.Canadian journal of psychiatry. 2012, Vol 57, Num 7, pp 406-413, issn 0706-7437, 8 p.Article

Placebo-Controlled, Antidepressant Clinical Trials Cannot Be Shortened to Less Than 4 Weeks' Duration: A Pooled Analysis of Randomized Clinical Trials Employing a Diagnostic Odds Ratio-Based ApproachTEDESCHINI, Enrico; FAVA, Maurizio; PAPAKOSTAS, George I et al.The Journal of clinical psychiatry. 2011, Vol 72, Num 1, pp 98-103, issn 0160-6689, 6 p.Article

Symptoms of fatigue and sleepiness in major depressive disorderBALDWIN, David S; PAPAKOSTAS, George I.The Journal of clinical psychiatry. 2006, Vol 67, pp 9-15, issn 0160-6689, 7 p., SUP6Article

Antidepressant dose reduction and the risk of relapse in major depressive disorderPAPAKOSTAS, George I; PERLIS, Roy H; SEIFERT, Cheryl et al.Psychotherapy and psychosomatics. 2007, Vol 76, Num 5, pp 266-270, issn 0033-3190, 5 p.Article

Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder : A meta-analysisPAPAKOSTAS, George I; SHELTON, Richard C; SMITH, Juliana et al.The Journal of clinical psychiatry. 2007, Vol 68, Num 6, pp 826-831, issn 0160-6689, 6 p.Article

Resolution of sleepiness and fatigue: A comparison of bupropion and selective serotonin reuptake inhibitors in subjects with major depressive disorder achieving remission at doses approved in the European UnionCOOPER, James A; TUCKER, Vivian L; PAPAKOSTAS, George I et al.Journal of psychopharmacology (Oxford). 2014, Vol 28, Num 2, pp 118-124, issn 0269-8811, 7 p.Article

Bioavailability of S-Adenosyl Methionine and Impact on Response in a Randomized, Double-Blind, Placebo-Controlled Trial in Major Depressive DisorderMISCHOULON, David; ALPERT, Jonathan E; ARNING, Erland et al.The Journal of clinical psychiatry. 2012, Vol 73, Num 6, pp 843-848, issn 0160-6689, 6 p.Article

Effects of S-adenosylmethionine augmentation of serotonin-reuptake inhibitor antidepressants on cognitive symptoms of major depressive disorderLEVKOVITZ, Yechiel; ALPERT, Jonathan E; BRINTZ, Carrie E et al.Journal of affective disorders. 2012, Vol 136, Num 3, pp 1174-1178, issn 0165-0327, 5 p.Article

S-Adenosyl Methionine (SAMe) Augmentation of Serotonin Reuptake Inhibitors for Antidepressant Nonresponders With Major Depressive Disorder: A Double-Blind, Randomized Clinical TrialPAPAKOSTAS, George I; MISCHOULON, David; SHYU, Irene et al.The American journal of psychiatry. 2010, Vol 167, Num 8, pp 942-948, issn 0002-953X, 7 p.Article

S-adenosyl methionine (SAMe) versus escitalopram and placebo in major depression RCT: Efficacy and effects of histamine and carnitine as moderators of responseSARRIS, Jerome; PAPAKOSTAS, George I; VITOLO, Ottavio et al.Journal of affective disorders. 2014, Vol 164, pp 76-81, issn 0165-0327, 6 p.Article

Efficacy of desvenlafaxine 50 mg compared with placebo in patients with moderate or severe major depressive disorder: a pooled analysis of six randomized, double-blind, placebo-controlled studiesPAPAKOSTAS, George I; CULPEPPER, Larry; FAYYAD, Rana S et al.International clinical psychopharmacology. 2013, Vol 28, Num 6, pp 312-321, issn 0268-1315, 10 p.Article

  • Page / 4